Randomised controlled trial of topical kanuka honey for the treatment of rosacea
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re:No evidence for kanuka honey being an effective treatment of rosacea
    • Irene E Braithwaite, Deputy Director
    • Other Contributors:
      • Professor R Beasley, Professor Mark Weatherall

    Messrs Schmidt and Schmidt, in their letter published in BMJ Open on 24 March 2016, assert that the study we reported about the effects of Kanuka honey in rosacea has a number of important flaws including problems with the experimental treatments, study design, and statistical analysis.

    With respect to the study medications the aim of the study was not to estimate the effect of a preparation of Kanuka honey with...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    No evidence for kanuka honey being an effective treatment of rosacea

    Braithwaite et al. [1] claim that kanuka honey is an effective treatment of rosacea. Both their study medication as well as their study design and statistical analysis are seriously flawed and do not allow this conclusion. First, the study medication is inappropriate to show an effect of kanuka honey. The verum was not kanuka honey (as the title suggests), but a mixture of kanuka honey and 10% glycerine (Honevo). As control...

    Show More
    Conflict of Interest:
    None declared.